Home » Japan’s Eisai to Launch Breast Cancer Drug in India
Japan’s Eisai to Launch Breast Cancer Drug in India
Japanese drugmaker Eisai is planning to launch its anti-cancer drug Eribulin, also known as Halaven, in India.
The Economic Times
The Economic Times
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May